Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
about
Striatal cholinergic interneuron regulation and circuit effectsDelayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in miceNeurosystems: brain rhythms and cognitive processing.New hypothesis and treatment targets of depression: an integrated view of key findings.The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
P2860
Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@en
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@nl
type
label
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@en
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@nl
prefLabel
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@en
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@nl
P2093
P2860
P1476
Rivastigmine reverses cognitiv ...... animal model of schizophrenia.
@en
P2093
Alexandra I Zugno
Alexandra S Heylmann
Ana Maria Volpato
Daiane B Fraga
Felipe D Pacheco
Josiane Budni
Mariana B de Oliveira
Pedro F Deroza
Renata D Luca
Ricardo Filipe Julião
P2860
P2888
P304
P356
10.1007/S11011-013-9417-Z
P50
P577
2013-06-19T00:00:00Z